| # | Side effect | Count |
|---|---|---|
| 0 | NO ADVERSE EVENT | 237 |
| 1 | DEVICE ISSUE | 211 |
| 2 | PRODUCT PREPARATION ISSUE | 184 |
| 3 | DEVICE LEAKAGE | 21 |
| 4 | INFUSION SITE EXTRAVASATION | 21 |
| 5 | DEEP VEIN THROMBOSIS | 20 |
| 6 | DRUG INEFFECTIVE | 19 |
| 7 | CEREBRAL INFARCTION | 14 |
| 8 | HAEMORRHAGE | 14 |
| 9 | PULMONARY EMBOLISM | 14 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | FACTOR XA ACTIVITY INCREASED | 1 | 0.0455 |
| 1 | PRODUCT PREPARATION ISSUE | 184 | 0.0280 |
| 2 | IMMATURE GRANULOCYTE PERCENTAGE INCREASED | 1 | 0.0164 |
| 3 | PRODUCT CLOSURE ISSUE | 7 | 0.0126 |
| 4 | INTRACARDIAC PRESSURE INCREASED | 1 | 0.0114 |
| 5 | MEDICAL DEVICE SITE THROMBOSIS | 1 | 0.0097 |
| 6 | SERRATIA SEPSIS | 1 | 0.0093 |
| 7 | HYPERTROPHIC SCAR | 1 | 0.0092 |
| 8 | FASCIOTOMY | 1 | 0.0089 |
| 9 | TRAUMATIC SHOCK | 1 | 0.0087 |